Turner White CommunicationsAbout TWCSubscribeContact TWCHomeSearch
Hospital PhysicianJCOMSMPBRMsCart
Current Contents
Past Issue Archives
Self-Assessment Questions
Review of
Clinical Signs
Clinical Review
Pediatric Rounds
Resident Grand Rounds
Article Archives
Case Reports
Clinical Practice
Pediatric Rounds
Resident Grand Rounds
Review of
Clinical Signs

Guide to Reading
Hospital Physician
Editorial Board
Information for Authors

Reprints, Permissions, & Copyright
Site Map
Self-Assessment Questions

Obstetrics & Gynecology

Answer 6
  1. Impaired glucose tolerance. Low-dose postmenopausal HRT has been shown to improve peripheral insulin resistance, prevent hyperinsulinemia, and reduce the risk for type 2 diabetes mellitus. In fact, the cardiovascular benefits of HRT may significantly help patients with diabetes mellitus. Estrogen is metabolized in the liver; therefore, HRT is contraindicated in patients with chronically impaired liver function. Endometrial adenocarcinoma is almost always an estrogen-sensitive cancer, and HRT is accordingly contraindicated. Breast cancer also is often an estrogen-sensitive cancer. After primary treatment of the breast cancer, metastatic cells may still be present and susceptible to exogenous hormones. Hypertriglyceridemia and pancreatitis can be precipitated by HRT administration in women with triglyceride levels between 250 and 750 mg/dL.

Click here to return to the questions


Hospital Physician     JCOM     Seminars in Medical Practice
Hospital Physician Board Review Manuals
About TWC    Subscribe    Contact TWC    Home    Search   Site Map

Copyright © 2009, Turner White Communications
Updated 1/04/08 • kkj